The Research and Development team at Rondo Therapeutics is responsible for discovering and developing novel bispecific antibodies to enhance the immune system's ability to fight cancer. This team conducts preclinical studies, translates biological discoveries into therapeutic candidates, and manages early-stage research projects to advance the company’s pipeline of innovative cancer treatments.
Elaine Chen, PhD
Scientist Ii, Translational Bi...
Imani Smith
Research Associate I
Katja Rüger
Scientist
Laura Davison
Senior Scientist
Manpreet Kaur
Associate Scientist and Assist...
Ruth Chu
Research scientist II
Soumili Chattopadhya...
Scientist 1
Starlynn Clarke
Director, Preclinical biology
Udaya Rangaswamy
Director, Translational Biolog...
View all